Shield Therapeutics Statistics

Total Valuation

AIM:STX has a market cap or net worth of GBP 28.02 million. The enterprise value is 43.87 million.

Market Cap	28.02M
Enterprise Value	43.87M

Important Dates

The last earnings date was Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

AIM:STX has 1.04 billion shares outstanding. The number of shares has increased by 8.33% in one year.

Current Share Class	1.04B
Shares Outstanding	1.04B
Shares Change (YoY)	+8.33%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	2.02%
Owned by Institutions (%)	31.21%
Float	388.25M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.09
PB Ratio	-26.64
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.02
EV / Sales	1.71
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.07

Financial Position

The company has a current ratio of 1.16

Current Ratio	1.16
Quick Ratio	0.90
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-3.88
Interest Coverage	-5.91

Financial Efficiency

Return on equity (ROE) is -396.35% and return on invested capital (ROIC) is -47.39%.

Return on Equity (ROE)	-396.35%
Return on Assets (ROA)	-26.90%
Return on Invested Capital (ROIC)	-47.39%
Return on Capital Employed (ROCE)	-92.02%
Revenue Per Employee	408,007
Profits Per Employee	-344,638
Employee Count	63
Asset Turnover	0.61
Inventory Turnover	3.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +75.82% in the last 52 weeks. The beta is 1.22, so AIM:STX's price volatility has been higher than the market average.

Beta (5Y)	1.22
52-Week Price Change	+75.82%
50-Day Moving Average	2.83
200-Day Moving Average	3.26
Relative Strength Index (RSI)	54.34
Average Volume (20 Days)	2,134,329

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, AIM:STX had revenue of GBP 25.70 million and -21.71 million in losses. Loss per share was -0.03.

Revenue	25.70M
Gross Profit	11.93M
Operating Income	-18.27M
Pretax Income	-21.21M
Net Income	-21.71M
EBITDA	-17.88M
EBIT	-18.27M
Loss Per Share	-0.03

Full Income Statement

Balance Sheet

The company has 5.21 million in cash and 21.06 million in debt, giving a net cash position of -15.85 million or -0.02 per share.

Cash & Cash Equivalents	5.21M
Total Debt	21.06M
Net Cash	-15.85M
Net Cash Per Share	-0.02
Equity (Book Value)	-1.05M
Book Value Per Share	-0.00
Working Capital	4.25M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.41 million and capital expenditures -27,957, giving a free cash flow of -5.44 million.

Operating Cash Flow	-5.41M
Capital Expenditures	-27,957
Free Cash Flow	-5.44M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 46.40%, with operating and profit margins of -71.08% and -84.47%.

Gross Margin	46.40%
Operating Margin	-71.08%
Pretax Margin	-82.52%
Profit Margin	-84.47%
EBITDA Margin	-69.56%
EBIT Margin	-71.08%
FCF Margin	n/a

Dividends & Yields

AIM:STX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.33%
Shareholder Yield	-8.33%
Earnings Yield	-77.48%
FCF Yield	-19.40%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AIM:STX has an Altman Z-Score of -6.64. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.64
Piotroski F-Score	n/a